Skip to menu Skip to content Skip to footer

2018

Conference Publication

Queensland Youth Cancer Service: a partnership model to facilitate access to quality care for young people diagnosed with cancer

Bradford, Natalie K., Henney, Roslyn, Walker, Rick, Walpole, Euan, Kennedy, Glen, Nicholls, Wayne and Pinkerton, Ross (2018). Queensland Youth Cancer Service: a partnership model to facilitate access to quality care for young people diagnosed with cancer. New Rochelle, NY, United States: Mary Ann Liebert. doi: 10.1089/jayao.2017.0080

Queensland Youth Cancer Service: a partnership model to facilitate access to quality care for young people diagnosed with cancer

2017

Conference Publication

Phase 1/2 KEYNOTE-051 study of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1<sup>+</sup> advanced, relapsed, or refractory solid tumor or lymphoma

Geoerger, Birgit, Kang, Hyoung Jin, Yalon-Oren, Michal, Marshall, Lynley V., Vezina, Catherine, Pappo, Alberto S., Laetsch, Theodore Willis, Petrilli, Antonio Sergio, Handgretinger, Rupert, Toporski, Jacek, Glade-Bender, Julia, Nicholls, Wayne, Fox, Elizabeth, DuBois, Steven G., Macy, Margaret, Cohn, Susan Lerner, Pathiraja, Kumudu, Diede, Scott J., Ebbinghaus, Scot and Pinto, Navin R. (2017). Phase 1/2 KEYNOTE-051 study of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1+ advanced, relapsed, or refractory solid tumor or lymphoma. 2017 ASCO Annual Meeting, Chicago, IL United States, 2 - 6 June 2017. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2017.35.15_suppl.10525

Phase 1/2 KEYNOTE-051 study of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1<sup>+</sup> advanced, relapsed, or refractory solid tumor or lymphoma